Here are the 10-Q quarterly reports from LataMed AI Corp (LMED) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow LMED and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LMED filings page.
LataMed AI Corp. reported no revenue for the three and six months ended June 30, 2026 and continues to invest in developing an AI-enabled digital healthcare platform focused on Latin America. A February 2026 asset purchase added intangible assets valued at $7,824,000, bringing total assets to that amount, all intangible, with no cash on hand.
The company recorded a net loss of $140,221 for the six months ended June 30, 2026, compared with $53,637 a year earlier, driven mainly by higher professional fees. Current liabilities were $771,081, resulting in a working capital deficit of the same amount and cumulative accumulated deficit of $29,741,007. Management states that these conditions raise substantial doubt about the ability to continue as a going concern and notes dependence on new financing. Debt consists of $355,722 in notes payable, $34,591 in convertible notes, and $88,042 in related-party notes, all generally at 10% interest and due on demand. During 2026, 12,000,000 common shares were issued for the acquired assets, and 20,000,000 common shares were exchanged for 5,000,000 non-convertible Series C Voting Preferred Stock, resulting in 36,134,795 common shares and 5,000,000 Series C preferred shares outstanding at June 30, 2026.